Use of Androgenic Anabolic Steroids linked to Increased Mortality Rates: JAMA

The findings of the study revealed a significant increase in mortality rates among AAS users when compared to the control group. Over the course of the study, 33 AAS users met untimely deaths, while 578 fatalities were observed in the control group. This discrepancy translated to a hazard ratio of 2.81 that indicates a substantially increased risk of mortality among AAS users.

Also, the causes of death among AAS users were deeply concerning, with the fatalities attributing to both natural and unnatural causes. The most prevalent natural causes included cancer and cardiovascular disease that underlined the severe health implications associated with AAS use. Unnatural deaths, primarily stemming from accidents were equally troubling which further emphasized the grave risks posed by these substances. While this study unveils invaluable light on the detrimental effects of AAS use, it also acknowledges the limitations including its observational nature and the absence of adjustments for potential confounding variables.

Source:

Windfeld-Mathiasen, J., Heerfordt, I. M., Dalhoff, K. P., Andersen, J. T., & Horwitz, H. (2024). Mortality Among Users of Anabolic Steroids. In JAMA. American Medical Association (AMA). https://doi.org/10.1001/jama.2024.3180